I'm pleased to present this paper we published with CMI recently on the potential use of flomoxef to treat infections caused by OXA-48 producing Enterobacterales. https://t.co/pSCBtvSy7U

Thank you to all the co-authors for their hard work with this. @VineetD1509 @Sara_E_Boyd @AleGerada @gardp_amr @APTlivuni

A little bit on my work on preventing #AMR for #WAAW22

Using antibiotics responsibly is vital to tackle #AMR. Dr @stephen_aston aims to use digital technologies to develop clinical decision support systems to guide clinicians on whether antibiotics are required. @livuniresthemes @LivUniISMIB @livuninews #WAAW2022

WATCH: Dr Vineet Dubey (@VineetD1509) tells us that new drugs are urgently needed for the treatment of multi-drug resistant bacteria and how he is developing isogenic mutants to help tackle #AMR #WAAW2022 @livuniresthemes @LivUniISMIB @livuninews

WATCH: Dr Katharine Stott tells us about her work in antimicrobial pharmacology - particularly in patients who are immunocompromised and require treatment for infections. #WAAW22 Find out more about our work➡️ https://t.co/lPQxVq43yy @livuniHLS @livuninews

Early career researcher @Anne8rete from @APTlivuni receives Rubicon award from the Dutch Research Council (NWO) to carry out research into new methods to combat emerging #viruses. Find out more about the award here: https://t.co/HnnCCOO4xP #AMR #APT

Excellent talks by all the young investigators Waheed Adedeji, Phoebe Williams and Vineet Dubey at the meeting today ⁦@ESCMID⁩ ⁦@APTlivuni⁩

So excited to share my work @pathanialab just accepted in @OUPAcademic describing repurposing of disulfiram that improves carbapenem activity against metallo-β-lactamase expressing Acinetobacter baumannii.